Patient-Centered Management in Pancreatic Cancer

Slides:

Advertisements

Similar presentations

Copyright © 2011 Research To Practice. All rights reserved. Case presented by Dr Schwartz 44 yo woman with 4 mo hx of abdominal pain –Imaging = pancreatic.

Advertisements

Copyright © 2011 Research To Practice. All rights reserved. Faculty National GI Tumor Board Clinical Investigators Provide Their Perspectives on Current.

Upfront Combination Therapy vs Step-Up Approach for PAH:

Applying the New Multiple Sclerosis Guidelines to Clinical Practice

Fostering a Collaborative Approach in the Management of BRCA-Mutated Ovarian Cancer.

The Nurse View: Management of Pancreatic Cancer

Endocrine Combinations in HR-Positive MBC: The Future Is Now

The Nurse View.

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Advanced NSCLC Without Actionable Mutations

New Patient Journeys in Non-small cell lung cancer

The Nurse View.

Progression After Cancer Immunotherapy in Advanced NSCLC

The Nurse View: Best Practices in Advanced Non-Small Cell Lung Cancer

Clinical Presentations of VTEa,b NOACs VTE Acute Treatment Trials.

Neoadjuvant Therapy in HER2-Positive Breast Cancer

The Nurse View: Updates in the Management of Metastatic Colorectal Cancer.

Activity Goals. Activity Goals Discussion Topics.

Optimizing Management of Advanced Bladder Cancer

Optimizing Targeted Therapy for HER2-Positive Advanced Breast Cancer: First-line Considerations.

Seizures in the Elderly: Treatment and Special Considerations

From Symptom Management to Communication in Advanced GI Cancers

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Practical Guidance on Using New Therapies for Relapsed/ Refractory Follicular Lymphoma and Chronic Lymphocytic Leukemia.

Opportunities and Challenges in the Management of Advanced STS

Managing Depression is a Team Effort:

ADVANCED PARKINSON'S DISEASE:

Advancing the Treatment of IBD With Biologics

Translating the Latest and Greatest Advances in PAH Into Clinical Practice.

Advancing Care Across the Spectrum of Pancreatic Cancer

Nurse View: Practice Pearls in Advanced Pancreatic Adenocarcinoma

Treating CD30-Expressing Cutaneous T-Cell Lymphoma

Personalizing Management in the Care of Patients With Advanced Sarcoma

Background. Advancing the Care of Patients With Moderate to Severe Atopic Dermatitis: A Case-Based Discussion.

When to Start and What to Use

The Road to Quality Improvement in HER2-Positive Breast Cancer

Hormone Receptor-Positive Advanced Breast Cancer Introduction

Cancer-Associated Thrombosis

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Panelists. Cardiovascular Risk Modulation in Diabetes: Emerging Pathways and Insights.

Treatment of Locally Advanced Pancreatic Cancer

Defining Patient-Centered Care: Spotlight on Advanced Non-Small Cell Lung Cancer.

Optimizing Targeted Therapy for HER2-Positive Advanced Breast Cancer: Considerations for Previously Treated Disease.

Managing Patients with Relapsed CLL who Discontinue BCR Signaling Inhibitors.

A Guideline-Based Approach to HCV Care

Management of Advanced Pancreatic Adenocarcinoma

The Changing Field of Melanoma: Ipilimumab.

Insulin in Diabetes Management: Effective Patient Selection Is Key

Patient-Centered Management in Advanced Non-Small Cell Lung Cancer

All for One: Multidisciplinary Management in EGFR-Mutated NSCLC

Individualizing Therapy for Patients With CLL in the Community Practice Setting: Focus on Age and Comorbidities.

Practical Guidance on the Management of Pan-Negative NSCLC

Communicating With Your Patients About Major Depressive Disorder

Improving Effective Basal Insulin Use in Clinical Practice

Improving Adherence to Antiplatelet Therapy After an ACS Event

Clinical Challenges and Updates in Managing Seizure Clusters

Case Studies in Locally Advanced Pancreatic Cancer

Getting PPG Under Control

AMD Therapy: Where Are We Now and Where Are We Going?

The Nurse View: Spotlight on EGFR-Mutated NSCLC

Treatment and diagnosis history, and response to targeted therapy, of a patient with pancreatic adenocarcinoma with an EGFR exon19 deletion. Treatment.

Clinical Pearls in the Management of Patients With Advanced Non-Small Cell Lung Cancer.

Evaluating the Totality of Evidence

Next-Generation Sequencing and ctDNA

Combining Immunotherapy and Chemotherapy in NSCLC

The Nurse View.

Care Team Collaboration for CAR T-Cell Therapy: Real-World Advice

Treatment Initiation and Selection in Newly Diagnosed CLL

The Nurse View: Practice Pearls in the Use of Immune Checkpoint Inhibitors in Advanced NSCLC.

Uncovering the Right Sequence

Presentation transcript:

Patient-Centered Management in Pancreatic Cancer

Activity Goals

Case Study 1: First-Line Therapy for Advanced Pancreatic Cancer

ACCORD Study: FOLFIRINOX vs Gemcitabine

Common AEs With Frontline Treatment of Pancreatic Cancer

Considerations When Selecting Therapies

Case Study 2: Progression on First-Line Therapy

Select Salvage Therapy Regimens

NAPOLI-1 Study: Nanoliposomal Irinotecan With Fluorouracil and Folinic Acid

NAPOLI-1 Study: Results

Educating and Communicating With Patients

Key Takeaways for Advanced/Metastatic Pancreatic Cancer

Key Takeaways for Advanced/Metastatic Pancreatic Cancer (cont)

Abbreviations